Navigation Links
Galil Medical Announces Establishment of Global Headquarters in Minneapolis, MN
Date:9/30/2009

MINNEAPOLIS, Sept. 30 /PRNewswire/ -- Galil Medical, a global leader in minimally invasive cryotherapy treatments for cancers and other disorders, announced today that it is establishing its new Global Headquarters in Minneapolis, MN. The company is expected to open this new facility in Arden Hills during the fourth quarter of 2009. Along with its corporate staff and US operations' functions, the company will also locate its global marketing, clinical/regulatory and its systems development and assembly functions in this new facility. Galil Medical will maintain needle manufacturing and R&D operations in its facility in Yokneam, Israel, as well as its European headquarters in London.

Martin J. Emerson, President and CEO, of Galil Medical comments: "We are excited about locating our Global Headquarters in Minneapolis. We feel the strong medical device presence in the greater Minneapolis and St. Paul area will give us access to a wide range of important resources and talent."

James E. Thomas, General Partner of Thomas, McNerney & Partners and member of Galil's Board of Directors, commented: "The decision to locate Galil's Global Headquarters in the Minneapolis area is part of our five year strategic plan recently approved by the Board of Directors. This plan includes the necessary funding for clinical data that will further document the value of cryotherapy for the focal treatment of prostate cancer and the treatment of renal cancer. Importantly, the plan also includes funding for advancing the state of the art cryotherapy technology."

Emerson concluded, "Galil Medical is now the only company solely devoted to the growth and development of cryotherapy. We have the experience, resources and commitment to pursue these goals for years to come."

About Galil Medical Galil Medical is a global medical device company that develops, manufactures and markets innovative products utilizing a proprietary cryoablation platform that incorporates powerful freezing technology and revolutionary 17-gauge cryoablation needle design. The company has offices in Yokneam, Israel; Plymouth Meeting, Pennsylvania; and London. Shareholders include Thomas, McNerney & Partners, The Vertical Group, Investor Growth Capital, Elron Electronic Industries Ltd. (Nasdaq: ELRN) and RDC Rafael Development Corporation, Ltd.

SOURCE Galil Medical


'/>"/>
SOURCE Galil Medical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Leading Medical Device Provider Chooses TrackWise(R) Software to Optimize Customer Complaint Handling
2. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
3. New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
4. American University of Beirut Medical Team Successfully Performs First Artificial Heart Implant in Lebanon
5. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
6. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
7. Medical World Recognises New Therapy for Reflux Babies
8. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
9. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
10. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
11. Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Ampio Pharmaceuticals, Inc. (NYSE MKT: ... entered into a Controlled Equity Offering SM Sales ... Michael Macaluso , Chairman and CEO, stated "During ... are not currently raising money and that we have ... 2017 and still complete all of our current objectives ...
(Date:2/11/2016)... Germany , February 11, 2016 ... up 6.8% to EUR 1,377.2m  Adjusted EBITDA climbs to ... 18.0% to EUR 3.41  Proposed dividend of EUR 0.85 ... sale of glass tubing business and refinancing successfully completed  ... to 5% on organic basis  Adjusted EBITDA expected ...
(Date:2/10/2016)... REDWOOD CITY, Calif., Feb. 10, 2016   Genomic Health, Inc. ... progress for the quarter and year ended December 31, 2015. ... in the fourth quarter of 2015, compared with $69.1 million in ... a constant currency basis, revenue increased 9 percent compared with the ... --> U.S. revenue was $63.9 million in the fourth ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... The Commission for ... the Board of Commissioners. Individuals interested in volunteer board service are encouraged to ... clinical practice settings and across allied health to contribute to its mission and ...
(Date:2/11/2016)... ... February 11, 2016 , ... Greenfield Insurance Group in Orange ... assist the people of their local community. The agency pledges to select a ... Their hope is to bring awareness to important local causes with fundraising and ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... ongoing community involvement program, introduces a new charity campaign to raise funds for ... now being accepted at https://donate.rmhc.org/ . , Ronald McDonald House (RMH) is ...
(Date:2/11/2016)... ... , ... Be Well Medical Group (Be Well) is pleased to ... 108 South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is a ... convenience of their homes, offices or at the practices’ local office. It is also ...
(Date:2/11/2016)... ... February 11, 2016 , ... Food Labeling for ... health and wellness best practices in the past couple of decades, and food ... American Heart Month, which acts as an exceptional opportunity to revise food labels ...
Breaking Medicine News(10 mins):